Digg It
#1 in Business Subscribe Email Print

You are here: Home > Finance > Credit > Balance Transfer Credit Cards - Why Switch Cards?

Tags

  • common
  • issuer
  • biological product
  • credit cards
  • minimum payments

  • Links

  • V.I.P. or S.A.D.?: It's up to You
  • How to Reach to the Stage Beyond Reason, and Why?
  • How Can I Fix Bad Credit
  • Digg It - Balance Transfer Credit Cards - Why Switch Cards?

    In recent years, credit cards have become a major component of everybody’s life. It started as a convenient spending tool but now it has become a reasonable way to
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    gain access to much needed credit in the form of cash and loans. Keeping a balance on a credit card account is today a very common thing and interest rates are a d
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    minant factor in peoples’ daily finance.

    As newer credit cards are issued every year, a balance transfer between credit cards is a common way for many to reduce th
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    eir monthly payments and fees to lending organizations. If the credit history is kept in good standing, a balance transfer can be much easier and rewarding as most
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    redit cards will be willing to grant a new loan to obtain future customers. Most credit cards offer introductory rates that are as low as zero percent and very ofte
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    n this low interest is kept up to twelve months.

    Clearly, if someone has a very high interest rate on a credit card, he or she will save a lot of money if he/she c
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    n transfer its’ entire balance into a different credit card. But a balance transfer between credit cards can actually be used effectively for years by switching fr
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    om one card to another while paying down the overall balance. But that is a dangerous game to play.

    Let’s take for example, Mr. X who opens a credit card account
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    t a given rate, say 7.99%. As he uses his card, he decides to carry a balance and just make the minimum payments. Within a few months, his balance or principal wil
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    l most likely be the same and his minimum payments will only be paying down a percentage of the interest. Let’s assume now that another credit card issuer offers a
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    .99% interest rate to Mr. X to transfer his balance. Mr. X will save 5% right off the bat by moving his balance. Furthermore, let’s assume that a year later a third
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    credit card issuer offers 0% interest rate. In this case, Mr. X can transfer the balance yet again, effectively eliminating the interest paid for the period offere
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    .

    But obtaining a balance transfer credit card has a few rules that need to be followed. We already mentioned the fact that your credit history must be in good sta
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    nding. The balance to be transferred should not be too high or at least in the price range that the other credit card is willing to lend. Another important factor i
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    fixed fees that are involved in balance transferring. Because of the potential for significant balance transfer fees, before making a final decision on balance tra
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    nsfer card it is very important to compare the net benefit of the card offer. Simply put, because of added fees and surcharges, the other credit card offering a lo
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    or even a 0% interest rate might not be sufficient to justify such transfer.

    At least two more elements must be taken into consideration regarding balance transfe
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    r credit cards. First to consider is the duration of the lower interest rate offer and second, is the amount of credit available for the actual transfer. The durati
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    n must be for a sufficient amount of time and the interest rate at the end of the promotional period must be lower or equal than the original interest rate. In this
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    case, it is possible to find many credit cards that will guarantee the same introductory interest rate for the entire life of the balance that has been transferred


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/92040/diggit-Balance-Transfer-Credit-Cards--Why-Switch-Cards.html">Balance Transfer Credit Cards - Why Switch Cards?</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/92040/diggit-Balance-Transfer-Credit-Cards--Why-Switch-Cards.html]Balance Transfer Credit Cards - Why Switch Cards?[/url]

    Related Articles:

    Retractable Banner Stands Are Long Term Investment

    An Instant Pay Raise Can Pay the Start Up Cost for Your Home Based Business!

    eBiz Marketing: Coffee Rocks

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com